Stock comparison
Banca Mediolanum S.p.A.
BMED.MI$16.29BFinancials Market cap, Sector
FinecoBank Banca Fineco S.p.A.
FBK.MI$13.61BFinancials Market cap, Sector
Overall winner
FinecoBank Banca Fineco S.p.A.
BMED.MI 34 FBK.MI
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
Fit scores by strategy
BMED.MI3wins
4winsFBK.MI
34F
D48
57D
C65
70B
C65
54D
D48
58D
F35
61C
B73
62C
C68
Side-by-side metrics
| Metric | BMED.MI | FBK.MI |
|---|---|---|
| Market cap | Winner: $16.29B | $13.61B |
| P/E (TTM) | Winner: 11.9x | 20.1x |
| EV/EBIT | - | - |
| ROIC (TTM) | - | - |
| Gross margin | - | - |
| Net margin | Winner: 50.72% | 41.67% |
| Revenue CAGR 5y | Winner: 20.04% | 12.67% |
| EPS CAGR 5y | Winner: 34.97% | 14.72% |
| Debt / Equity | Winner: 0.1x | 0.3x |
| Dividend yield | - | - |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
BMED.MI leads on
- Debt / Equity0.1xvs 0.3x+75%
- EPS CAGR 5y34.97%vs 14.72%+58%
- P/E (TTM)11.9xvs 20.1x+41%
- Revenue CAGR 5y20.04%vs 12.67%+37%
FBK.MI leads on
No clear edges - the other side wins or ties on every measured metric.
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.